Brenda Raud

Dr. Brenda Raud

Dr. Brenda Raud is a postdoctoral researcher in the Division of Molecular Oncology and Immunology at the Netherlands Cancer Institute, in Amsterdam. She studied biotechnology in Argentina, and later received her PhD in Immunology from the Hannover Medical School in Germany. During her doctorate, she characterized the metabolism of T cells and the mechanisms by which metabolic pathways can shape the immune response in health and disease. Dr. Raud is currently researching the role of lymphocytes in the immune response against cancer and developing therapies which harness the power of T cells to treat a range of solid tumors. Besides being passionate about science and the intricacies of the immune system, Dr. Raud is an enthusiastic expat: she has lived in three countries, done research in five, and is keen on picking up languages along the way.

Jason Goldsmith

Dr. Jason Goldsmith

Jason Goldsmith is Director of Donor Medical Sciences at Seres Therapeutics, a biotechnology company working to revolutionize treatment of a wide range of dieases by modulating the function of the human microbiome. He was previously a postdoctoral researcher at the University of Pennsylvania’s Institute for Immunology, where he studied the intersection of intestinal regeneration, intestinal immunity, and host-microbiome interactions with the goal of one day being able to control intestinal regeneration therapeutically, both to enhance it during inflammatory processes (such as Colitis, Crohn’s, or radiation-induced enteropathy) or selectively inhibit it in colorectal cancer. He completed 2 years of internal medicine residency at the University of Michigan before deciding to focus on a research career, and still works part time as a hospitalist. Jason used to be a professional martial arts instructor, and still trains in his free time. He also enjoys role-playing games and the occasional video game.